← back to search

John Greenlee

George E. Wahlen Department of VA Medical Center · US
Area of research
Neurology · Oncology
Research interest
Research interests include Autoimmune Neurological Disorders and Treatments, Polyomavirus and related diseases, Peripheral Neuropathies and Disorders, and Genetic Neurodegenerative Diseases.
h-index
32
citations
3,069
works
202
NIH funding
primary concept
email

Recent publications

Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis
Frontiers in Neurology 2022cited by 40position: firstdoi
The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease
The Cerebellum 2022cited by 9position: firstdoi
Modern Look at Transverse Myelitis and Inflammatory Myelopathy
Neurology Neuroimmunology & Neuroinflammation 2021cited by 24position: middledoi
Neurosarcoidosis
Neurology Neuroimmunology & Neuroinflammation 2020cited by 40position: middledoi
Paraneoplastic Diseases of the Central Nervous System
F1000Research 2020cited by 26position: lastdoi
Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing
JAMA Neurology 2018cited by 312position: middledoi
Lambert–Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population
Muscle & Nerve 2016cited by 43position: middledoi
Voltage-gated calcium channel autoimmune cerebellar degeneration
Neurology Neuroimmunology & Neuroinflammation 2016cited by 18position: lastdoi
Anti-Yo Antibody Uptake and Interaction with Its Intracellular Target Antigen Causes Purkinje Cell Death in Rat Cerebellar Slice Cultures: A Possible Mechanism for Paraneoplastic Cerebellar Degeneration in Humans with Gynecological or Breast Cancers
PLoS ONE 2015cited by 61position: firstdoi
Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures
Journal of Neuroinflammation 2014cited by 58position: firstdoi
Treatment of Paraneoplastic Cerebellar Degeneration
Current Treatment Options in Neurology 2013cited by 60position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Stacey Clardy · University of Utah7 papers (2014–2022)Noel G. Carlson · University of Utah5 papers (2014–2022)Blair Wood · Retina Associates3 papers (2014–2016)Kenneth E. Hill · Neurology, Inc3 papers (2014–2016)Susan Clawson · Neurology, Inc3 papers (2014–2016)Jonathan Galli · University of Utah3 papers (2020–2021) · 2 papers (2014–2015)M. Mateo Paz Soldán · Mayo Clinic2 papers (2020–2021)John Rose · University of Utah2 papers (2020–2021)Justin Abbatemarco · Cleveland Clinic2 papers (2021–2022) · 1 papers (2022–2022)Ka‐Ho Wong · University of Utah1 papers (2021–2021)Mark B. Bromberg · University of Utah1 papers (2016–2016)H. Robert Brashear · University of Virginia1 papers (2022–2022)Daniel C. Abenroth · University of Utah1 papers (2016–2016)Julia Klein · University of Cologne1 papers (2020–2020)A. G. Smith · The University of Queensland1 papers (2016–2016)Verena Samara · University of Nevada, Reno1 papers (2021–2021)Troy D. Jaskowski · ARUP Laboratories (United States)1 papers (2014–2014)Christian A. Vedeler · Université Claude Bernard Lyon 11 papers (2022–2022)